Back to first-pass browser

First-pass extracted concept

circadian modulators

Candidate: concept label1 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Circadian modulators are presented as small-molecule interventions acting on circadian-clock-related factors in cancer. The review frames them as potential chemotherapy agents.

Source 1DOIPubMed

What problem it solves

They are proposed as a way to exploit circadian-cycle deregulation for understanding carcinogenicity and identifying new anti-neoplastic therapies.

Source 1DOIPubMed

What it does not solve

The abstract does not show that circadian modulators are universally effective across cancers or that one modulation direction works in all settings.

Source 1DOIPubMed

Alternatives

The abstract contrasts no specific alternative therapeutic classes, but it implies broader chemotherapeutic approaches outside circadian targeting.

Source 1DOIPubMed

Evidence Snippets

This review therefore summarizes and systematizes existing knowledge regarding the effectiveness of circadian modulators as chemotherapy agents
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1context dependencesupports2025Source 1DOIPubMed

Circadian modulators can act as receptor agonists or inverse agonists depending on the specific characteristics of a particular cancer.

Claim 2review scope summarysupports2025Source 1DOIPubMed

Circadian clock disruption is linked to cancer and is presented as a growing research area.

Claim 3therapeutic potentialsupports2025Source 1DOIPubMed

Investigating circadian cycle deregulation may help identify new chemotherapeutics targeted at neoplastic cells.